Edgar Wiebe

Berlin, BE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Rapid and profound treatment response of difficult-to-treat rheumatoid arthritis to CD19 CAR T-cell therapy.

Rapid and profound treatment response of difficult-to-treat rheumatoid arthritis to CD19 CAR T-cell therapy.

Journal: EULAR rheumatology open

Published: August 01, 2026

Blinatumomab in refractory SLE-associated immune thrombocytopenia.

Blinatumomab in refractory SLE-associated immune thrombocytopenia.

Journal: Annals of the rheumatic diseases

Published: July 01, 2026

BCMA-directed therapy with cizutamig induces rapid improvement in long-standing systemic sclerosis-associated interstitial lung disease.

BCMA-directed therapy with cizutamig induces rapid improvement in long-standing systemic sclerosis-associated interstitial lung disease.

Journal: Rheumatology (Oxford, England)

Published: June 23, 2026

Rheumatoid arthritis-more than just a joint disease : Overview for internal medicine practice

Rheumatoid arthritis-more than just a joint disease : Overview for internal medicine practice

Journal: Innere Medizin (Heidelberg, Germany)

Published: March 30, 2026

CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial.

CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial.

Journal: Nature medicine

Published: March 20, 2026

Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis-a case series.

Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis-a case series.

Journal: Annals of the rheumatic diseases

Published: January 19, 2026

Teclistamab for treatment-refractory autoimmune diseases: a multicentre case series.

Teclistamab for treatment-refractory autoimmune diseases: a multicentre case series.

Journal: Annals of the rheumatic diseases

Published: January 19, 2026

Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome.

Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome.

Journal: Annals of the rheumatic diseases

Published: September 07, 2025

Confounding by indication in observational studies investigating glucocorticoid-associated adverse events in patients with rheumatoid arthritis: a systematic literature review including an assessment of E-values.

Confounding by indication in observational studies investigating glucocorticoid-associated adverse events in patients with rheumatoid arthritis: a systematic literature review including an assessment of E-values.

Journal: Annals of the rheumatic diseases

Published: May 30, 2025

Lupus nephritis and U1-RNP-antibodies are associated with low bone mineral density and osteoporosis in patients with systemic lupus erythematosus: baseline findings in a sub-cohort of patients with inflammatory rheumatic diseases.

Lupus nephritis and U1-RNP-antibodies are associated with low bone mineral density and osteoporosis in patients with systemic lupus erythematosus: baseline findings in a sub-cohort of patients with inflammatory rheumatic diseases.

Journal: Arthritis research & therapy

Published: April 04, 2025

Clinical Impact of Multiparametric Contrast-Enhanced Dual-Energy Computed Tomography in Arthritis Imaging: A Prospective Single-Center Study.

Clinical Impact of Multiparametric Contrast-Enhanced Dual-Energy Computed Tomography in Arthritis Imaging: A Prospective Single-Center Study.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 09, 2025

"Paradoxical fractures": pathological fractures under anti-osteoporotic and antirheumatic treatment

"Paradoxical fractures": pathological fractures under anti-osteoporotic and antirheumatic treatment

Journal: Zeitschrift fur Rheumatologie

Published: January 04, 2025

Showing 1-12 of 27

Last Updated: 09/26/2026